Related Experiment Video
Updated: Jul 25, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
PAG neuronal NMDARs activation mediated morphine-induced hyperalgesia by HMGB1-TLR4 dependent microglial inflammation
Jingjing Mo1, Zijing Lu2, Jialing Peng3
1Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Abstract:
Morphine is one of the most effective and widely used analgesic drugs. However, chronic morphine use caused opioid-induced hyperalgesia (OIH). The development of OIH limits the use of morphine. The mechanisms of OIH are not fully understood. Toll-like receptor4 (TLR4) and glutamate receptors in the periaqueductal gray (PAG) are critical in OIH, however, the association between TLR4 and N-methyl-D-aspartate Receptors (NMDARs) activation in PAG remains unclear. Microglia activation, increased TLR4/p65 nuclear factor-kappa B (p65 NF-κB) and proinflammatory cytokines in microglia, and phosphorylation of NMDAR1 subunit (NR1) and NMDAR2B subunit (NR2B) in neurons were observed in PAG of OIH mice. Up-regulations of TLR4/p65 NF-κB and proinflammatory cytokines (IL-1β, IL-6, TNF-α) in BV2 cells were prevented by inhibiting and knocking down TLR4. By inhibiting myeloid differentiation factor 2 (MD2) and knocking down the High-mobility group box 1 (HMGB1), we found that morphine activated TLR4 by HMGB1 but not MD2. We co-cultured Neuro-2a (N2A) with BV2 microglial cell line and found that instead of directly phosphorylating NMDAR subunits, morphine increased the phosphorylation of NR1 and NR2B by inducing TLR4-mediated microglia inflammation. Knocking TLR4 out of PAG by Lentivirus-GFP-TLR4 shRNA reversed these changes and relieved OIH. Our findings suggested that the secretion of HMGB1 induced by morphine-activated TLR4 in microglia, and the proinflammatory factors released by activated microglia phosphorylated NR1 and NR2B of adjacent neurons, induced increased neuronal excitability. In conclusion, TLR4/NMDARs in PAG were involved in the development and maintenance of OIH and supported novel strategies for OIH treatment.
Insights
Chronic morphine use causes opioid-induced hyperalgesia (OIH) via Toll-like receptor 4 (TLR4) activation in the periaqueductal gray. This pathway involves High-mobility group box 1 (HMGB1) and microglia, leading to neuronal hyperexcitability and OIH.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Opioid-induced hyperalgesia (OIH) is a significant clinical challenge limiting morphine's analgesic efficacy.
- The precise mechanisms underlying OIH, particularly the roles of Toll-like receptor 4 (TLR4) and glutamate receptors in the periaqueductal gray (PAG), remain incompletely understood.
Purpose of the Study:
- To elucidate the association between TLR4 and N-methyl-D-aspartate Receptors (NMDARs) activation in the PAG during OIH.
- To investigate the role of microglia and specific molecular pathways in morphine-induced hyperalgesia.
Main Methods:
- Utilized a mouse model of OIH, observing microglia activation, TLR4/p65 NF-κB signaling, and NMDAR subunit phosphorylation in the PAG.
- Employed cell cultures (BV2, N2A) to examine TLR4 activation by High-mobility group box 1 (HMGB1) and its downstream effects on NMDARs.
- Intervened using TLR4 inhibition, knockdown, and knockout (Lentivirus-GFP-TLR4 shRNA) to assess their impact on OIH.
Main Results:
- Morphine induced microglia activation, increased TLR4/p65 NF-κB, and pro-inflammatory cytokines in the PAG and BV2 cells.
- Morphine activated TLR4 via HMGB1, not MD2, leading to microglia-derived inflammation that phosphorylated NMDAR subunits (NR1, NR2B) in adjacent neurons.
- TLR4 knockout in the PAG reversed these molecular changes and significantly alleviated OIH symptoms.
Conclusions:
- Morphine-induced OIH involves TLR4 activation in PAG microglia, mediated by HMGB1.
- Activated microglia release inflammatory factors that phosphorylate NMDARs in neurons, increasing excitability and contributing to OIH.
- Targeting the TLR4/NMDAR pathway in the PAG presents a promising therapeutic strategy for managing OIH.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview

